Research Consortia, Centers & Institutes


 

(* co-listed as a University Research Center/Institute)

Center for Research and Training in the Sciences (CRTS) *

CRTS was established to maximize resource sharing of extramural programs with similar or complimentary goals in scientific research and training. General charge of this center is the responsibility of all institutional grants designed to strengthen the capacity of UTSA in the broad area of Life Sciences.

UTSA Brain Health Consortium (BHC)

The BHC is a collaborative, multi-disciplinary team committed to discovering the inner workings of the brain. It integrates researchers with expertise in neuroscience, regenerative medicine, medicinal chemistry, biomedical engineering, and data analytics, with the common goal of applying those discoveries to prevent and treat neurological disorders.

UTSA Neurosciences Institute *

The UTSA Neurosciences Institute is the multidisciplinary research organization for the neurosciences at UTSA. The institute's mission is to foster a collaborative community of scientists committed to studying the biological basis of human experience and behavior, and the origin and treatment of nervous system diseases.

Aligned with the Biology Department

San Antonio Cellular Therapeutics Institute (SACTI) *

SACTI facilitates research on aspects of cell and molecular biology in nonhuman primates, with particular emphases on research relating to primate embryology, stem cell biology, biogenesis research, regenerative medicine, and basic developmental biology.

South Texas Center for Emerging Infectious Diseases (STCEID) *

STCEID focuses on the study of infectious microorganisms and the host immune response to these microorganisms. It is committed to advancing and expanding research in bacteriology, mycology, virology, parasitology, and immunology while training the next generation of infectious disease researchers.

Aligned with the Chemistry Department

Center for Innovative Drug Discovery (CIDD) *

CIDD provides a diverse array of core facilities and expertise to facilitate the translation of basic scientific discoveries into tangible pre-clinical candidate drugs that can be further developed into clinical therapies for human disease.

Aligned with the Computer Science Department

Center for Infrastructure Assurance and Security (CIAS) *

CIAS is developing the world's foremost center for multidisciplinary education and development of operational capabilities in the areas of infrastructure assurance and security. The center conducts scenario-based cyber security preparedness exercises to test an organization's communication, incident response, disaster recovery, business continuity and security awareness.

Institute for Cyber Security (ICS) *

The ICS pursues world-leading research with real-world impact, including development of commercializable technologies and services. Its core competencies in cyber security encompass research excellence, preparedness exercises, training, and competitions.

Aligned with the Geological Sciences Department

Center for Water Research (CWR) *

CWR is committed to advancing scientific and engineering knowledge in water resources through interdisciplinary research at local, national, and international levels to help find solutions to complex interdisciplinary problems in water resources.

Aligned with the Physics & Astronomy Department

International Center for Nanotechnology and Advanced Materials (ICNAM)

ICNAM is dedicated to promoting partnerships, networking, and interactions between scientists and engineers of the UT System and high quality education and research institutions of Latin America. The center produces world class research and develops technologies based on materials science that will launch new high tech industries.

Kleberg Advanced Microscopy Center (KAMC)

The KAMC houses the JEOL JEM-ARM200F transmission electron microscope which is used for world-class research in nanotechnology, biology, chemistry, geology, engineering, and medicine. One of only two in the world, this microscope is propelling the development of new cancer therapies and disease treatments.